Shock

• FDA approval · 2025-05-30
  FDA Approved: PHENYLEPHRINE HYDROCHLORIDE INJECTION, SOLUTION — Original Application (Dr. Reddy's Laboratories Inc.)

  FDA approved phenylephrine hydrochloride injection, solution from Dr. Reddy's Laboratories Inc. as an Original Application. The product is i…

• FDA approval · 2024-12-03
  FDA Approved: NOREPINEPHRINE — Supplemental Application (Long Grove Pharmaceuticals, LLC)

  FDA approved a supplemental application for norepinephrine bitartrate (NOREPINEPHRINE) from Long Grove Pharmaceuticals, LLC under NDA 214628…

• FDA approval · 2024-11-05
  FDA Approved: DOPAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for dopamine hydrochloride injectable from Hikma Pharmaceuticals USA Inc., confirming continued appr…

• EMA approval · 2024-09-25
  EMA Authorised: Giapreza (angiotensin II acetate) — Paion Pharma GmbH

  Giapreza (angiotensin II acetate) has been authorised by the EMA for adults with hypotension and shock, under Paion Pharma GmbH, with a deci…

• FDA approval · 2024-05-13
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved a generic norepinephrine bitartrate injection under an original ANDA from Rising Pharma Holdings, Inc. for use in the managemen…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-01-29
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved norepinephrine bitartrate injection from Sun Pharmaceutical Industries as an original-application generic product.

• FDA approval · 2020-09-28
  FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

  FDA approved a supplemental application for norepinephrine bitartrate from Meitheal Pharmaceuticals Inc. to market this generic product.

• FDA approval · 2020-08-12
  FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Civica, Inc.)

  FDA approved Civica, Inc.'s supplemental application for norepinephrine bitartrate (ANDA 211359).

• FDA approval · 2012-03-27
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Baxter Healthcare Corporation)

  FDA approved norepinephrine bitartrate under Baxter Healthcare Corporation's original application; the drug is used as a vasopressor to rais…